Prevention & care
Hepatitis A: spread, recovery and prevention after exposure
On this page
Hepatitis means inflammation of the liver; hepatitis A is the form caused by hepatitis A virus, or HAV. Infection usually causes a short-term illness, although severity varies. The virus spreads when it is swallowed, often through close personal contact or contaminated food or water. It is a different virus from hepatitis B or C.[1]
Infection, clinical illness and complications are different categories
Asymptomatic infection means virus is present without noticeable illness. Symptomatic acute disease may involve fatigue, poor appetite, nausea, dark urine and jaundice. Prolonged or relapsing illness can continue for months; a recurrence of symptoms is different from a lifelong chronic HAV infection. Rare fulminant hepatitis means acute liver failure and is a severe complication, not the usual course.[6]
Food contamination is one route, not the whole explanation
HAV is spread through swallowing very small amounts of virus. Food or water can become contaminated, while close contact also allows spread. Someone may transmit infection before realizing they are ill. Handwashing after bathroom use or changing diapers and before preparing food reduces opportunities for transmission; outward cleanliness or absence of jaundice does not prove a person cannot spread HAV.[1]
The interval after exposure makes recall difficult
Symptoms may begin several weeks after exposure rather than immediately after a particular meal. Fever, digestive symptoms and jaundice can have other causes, and children often have less noticeable illness than adults. Seek medical assessment for suspected hepatitis rather than using a symptom list to decide which virus is responsible. A known exposure matters even before symptoms occur.[2]
Antibodies to recent infection and past immunity are different tests
IgM anti-HAV supports recent or current infection in the appropriate clinical context. IgG anti-HAV indicates immunity from previous infection or vaccination. Total antibody measures do not by themselves distinguish these situations. CDC cautions against indiscriminate IgM testing: false positivity or cross-reactivity can occur. Clinical history and exposure remain important when interpreting a result.[3]
Routine protection and postexposure protection have different timing
US guidance recommends childhood vaccination and vaccination for specified risk groups, including chronic liver disease; any adult requesting protection may be vaccinated. Single-antigen products protect against HAV, while an adult combination product covers hepatitis A and B. Their schedules and age restrictions differ. Completing the relevant course provides longer-term protection; country-specific recommendations can differ.[4]
After a relevant exposure, contact a clinician or public-health service promptly. Vaccine, immune globulin or both may prevent illness when given within two weeks; selection depends on age, health and prior vaccination. Waiting for a blood-test result or for jaundice to appear can miss that prevention window. This is a time-sensitive clinical decision, not a home medicine recipe.[2]
Supportive care is active care even without a specific antiviral
Most people recover, but supportive care may be needed for hydration, nutrition and monitoring; severe illness may require hospital care. No specific antiviral is routinely used to cure hepatitis A. Relapse and the rare severe complication are reasons to reassess a changing course. An average recovery time does not establish that ongoing symptoms in one person are safe to ignore.[5]
Evidence & uncertainty
Hepatitis A does not ordinarily become a chronic infection like hepatitis B or C can. That distinction does not mean every episode is harmless: older people and those with existing liver disease can face greater risks, and outbreaks require timely public-health prevention.[5][7]
Selected-source overview · Independent review pendingPublished questions
Does hepatitis A become chronic hepatitis?
Selected-source overview · Independent review pending. Read the evidence context.
It does not ordinarily cause chronic infection. Prolonged or relapsing symptoms are different from lifelong infection with another hepatitis virus.[6]
Evidence behind this answer
- Pink Book Chapter 9: Hepatitis A
agency clinical guidance · 2024
Selected relevant page text, guideline passages, or publication abstract inspected · Clinical spectrum, prolonged/relapsing disease and complication context
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a positive IgG result mean I currently have hepatitis A?
Selected-source overview · Independent review pending. Read the evidence context.
Not by itself. IgG reflects immunity after vaccination or infection; diagnosing acute disease uses the appropriate tests and clinical context.[3]
Evidence behind this answer
- Clinical Screening and Diagnosis for Hepatitis A
agency clinical guidance · 2024
Selected relevant page text, guideline passages, or publication abstract inspected · IgM/IgG distinctions, false positivity, clinical context and testing scope
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should I wait for symptoms after an exposure?
Selected-source overview · Independent review pending. Read the evidence context.
No. Prompt clinical or public-health advice matters because preventive vaccine or immune globulin is most useful within two weeks.[2]
Evidence behind this answer
- Symptoms of Hepatitis A
agency explanation · 2024
Selected relevant page text, guideline passages, or publication abstract inspected · Exposure-to-symptom delay, symptoms, and prompt postexposure prevention
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can a child spread HAV without jaundice?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. Children often have less noticeable illness, and transmission can occur without obvious symptoms.[1]
Evidence behind this answer
- Hepatitis A Basics
agency explanation · 2025
Selected relevant page text, guideline passages, or publication abstract inspected · HAV spread, symptoms, hygiene and supportive recovery
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are hepatitis A and hepatitis B shots interchangeable?
Selected-source overview · Independent review pending. Read the evidence context.
No. Single-antigen HAV vaccines and the adult HAV/HBV combination differ in what they cover and their schedules.[4]
Evidence behind this answer
- Hepatitis A Vaccine Administration
agency clinical guidance · 2025
Selected relevant page text, guideline passages, or publication abstract inspected · US recommendations, inactivated product types, age groups and dose schedules
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why can advice differ for two people?
Selected-source overview · Independent review pending. Read the evidence context.
Prior immunity, age, liver disease, exposure and national guidance affect preventive decisions. A broad public description cannot select one regimen for everyone.[4]
Evidence behind this answer
- Hepatitis A Vaccine Administration
agency clinical guidance · 2025
Selected relevant page text, guideline passages, or publication abstract inspected · US recommendations, inactivated product types, age groups and dose schedules
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A vaccine safety report is not proof of causation
The vaccine information statement describes soreness, tiredness or other short-lived reactions and rare serious allergic reactions. A medical event after vaccination may have another cause; evaluating causation differs from recording that it happened afterward. Discuss a previous severe allergic reaction and current health context with the vaccinating clinician. The prevention decision weighs exposure and disease consequences alongside treatment risks.[7]
References
- Hepatitis A Basics
Agency explanation
CDC · Content/publication date: 2025
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: HAV spread, symptoms, hygiene and supportive recovery - Symptoms of Hepatitis A
Agency explanation
CDC · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: Exposure-to-symptom delay, symptoms, and prompt postexposure prevention - Clinical Screening and Diagnosis for Hepatitis A
Agency clinical guidance
CDC · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: IgM/IgG distinctions, false positivity, clinical context and testing scope - Hepatitis A Vaccine Administration
Agency clinical guidance
CDC · Content/publication date: 2025
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: US recommendations, inactivated product types, age groups and dose schedules - Hepatitis A fact sheet
Agency explanation
WHO · Content/publication date: 2026
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: Nonchronic disease, sanitation, severity, relapse and global vaccination contextIts laboratory paragraph has an IgG/IgM wording inconsistency; the atlas uses CDC’s explicit IgM/IgG explanation instead.
- Pink Book Chapter 9: Hepatitis A
Agency clinical guidance
CDC · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: Clinical spectrum, prolonged/relapsing disease and complication context - Hepatitis A Vaccine Information Statement
Agency vaccine information
CDC · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: Benefits, common reactions and rare serious allergic reactions
Scope & review
- Population
- General adults and families; vaccination and postexposure selection require individual and jurisdictional context
- Exposure or intervention
- Definitions, classification, assessment, prevention and condition-specific care
- Comparison
- Different causes and subtypes; selected intervention comparisons
- Outcomes
- Symptoms, function, complications, treatment harms and uncertainty
- Timeframe
- Acute illness and/or long-term follow-up as specified
- Jurisdiction
- US agency explanations and international or UK guidelines; local pathways differ
Targeted selected-source educational explanation. Not an exhaustive systematic review or individualized treatment plan; qualified medical review remains pending.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added foundation-first explanation, categories, targeted primary sourcing, scientific uncertainty and linked reading.
What this article still leaves open
- A full comparison of subtype-specific management and long-term outcomes; selected sources do not constitute a systematic synthesis.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.